Experimental Ebola Vaccines
- All
- News
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
Ebola Vaccine May Soon Become a Reality
An experimental Ebola vaccine has been found to be safe for humans, according to the results of an early clinical trial.
-
Experimental Vaccine Could Provide Rapid Response To Diseases
A type of experimental vaccine that can be made in just a week and has protected mice against influenza, Ebola and Zika viruses may offer promise for quick responses to disease outbreaks in people, according to Massachusetts Institute of Technology researchers.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
Ebola Vaccine Trial Begins in Sierra Leone
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.
-
Ebola Vaccine Tests Show it Could 'Neutralise' Virus: Geneva Hospital
An experimental Ebola vaccine tested on humans in Europe and Africa sparks the production of the antibodies needed to neutralise the deadly virus, a Geneva hospital said Wednesday.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
Japanese Firm Says Ebola Drug Tests Offers 'Hope'
The Japanese company behind an experimental Ebola treatment says it offers new hope for thousands of people infected with the deadly virus in west Africa, but acknowledged it is "not a miracle drug".
-
Ebola Vaccine is Safe, Say Researchers
Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the US National Institutes of Health suggest it is safe for use, researchers said on Wednesday.
-
First GSK Ebola Vaccine Shipment Due to Arrive In Liberia
The first batch of GlaxoSmithKline's experimental Ebola vaccine has been dispatched to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said.
-
Two Ebola Vaccines Safe, Trials Conclude
A trial of two experimental DNA vaccines to prevent infection by the Ebola virus has confirmed that these are safe, generating a similar immune response in healthy Ugandan adults as reported in US adults earlier this year.
-
Ebola Vaccine from Glaxo Passes Early Safety Test
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
-
Canada to Begin Ebola Vaccine Trials
Canada is starting trials of its experimental Ebola vaccine on a small group of people in the Atlantic port city of Halifax, Health Minister Rona Ambrose announced Friday.
-
Canadian Ebola Vaccine to be Tested in Europe, Gabon, Kenya
Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust.
-
Ebola Drug Maker Fujifilm to Buy US Vaccine Maker
Fujifilm said on Monday it would buy a US vaccine maker as the Japanese firm boosts its supply of an experimental Ebola drug to help stem the spread of the virus.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
Ebola Vaccine May Soon Become a Reality
An experimental Ebola vaccine has been found to be safe for humans, according to the results of an early clinical trial.
-
Experimental Vaccine Could Provide Rapid Response To Diseases
A type of experimental vaccine that can be made in just a week and has protected mice against influenza, Ebola and Zika viruses may offer promise for quick responses to disease outbreaks in people, according to Massachusetts Institute of Technology researchers.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
Ebola Vaccine Trial Begins in Sierra Leone
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.
-
Ebola Vaccine Tests Show it Could 'Neutralise' Virus: Geneva Hospital
An experimental Ebola vaccine tested on humans in Europe and Africa sparks the production of the antibodies needed to neutralise the deadly virus, a Geneva hospital said Wednesday.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
Japanese Firm Says Ebola Drug Tests Offers 'Hope'
The Japanese company behind an experimental Ebola treatment says it offers new hope for thousands of people infected with the deadly virus in west Africa, but acknowledged it is "not a miracle drug".
-
Ebola Vaccine is Safe, Say Researchers
Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the US National Institutes of Health suggest it is safe for use, researchers said on Wednesday.
-
First GSK Ebola Vaccine Shipment Due to Arrive In Liberia
The first batch of GlaxoSmithKline's experimental Ebola vaccine has been dispatched to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said.
-
Two Ebola Vaccines Safe, Trials Conclude
A trial of two experimental DNA vaccines to prevent infection by the Ebola virus has confirmed that these are safe, generating a similar immune response in healthy Ugandan adults as reported in US adults earlier this year.
-
Ebola Vaccine from Glaxo Passes Early Safety Test
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
-
Canada to Begin Ebola Vaccine Trials
Canada is starting trials of its experimental Ebola vaccine on a small group of people in the Atlantic port city of Halifax, Health Minister Rona Ambrose announced Friday.
-
Canadian Ebola Vaccine to be Tested in Europe, Gabon, Kenya
Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust.
-
Ebola Drug Maker Fujifilm to Buy US Vaccine Maker
Fujifilm said on Monday it would buy a US vaccine maker as the Japanese firm boosts its supply of an experimental Ebola drug to help stem the spread of the virus.
